Translational Development Acquisition TDACU
NASDAQ TDACU
$11.48 +0.00 (+0.00%)
At close: Nov 5, 2026 · 4:00 PM EST

Translational Development Acquisition (TDACU) Change in Accrued Expenses (2024 - 2026)

Updated

Translational Development Acquisition (TDACU) recorded Change in Accrued Expenses of $260,465 in Q2 2026, compared with -$62,557 a year earlier.

Analysis

Translational Development Acquisition (TDACU) Change in Accrued Expenses (2024 - 2026) Analysis & Trends

On a TTM basis, Translational Development Acquisition's Change in Accrued Expenses came in at $246,868 as of Jun 30, 2026; for FY2025, it came in at $29,008.

  • Across earlier years, Change in Accrued Expenses came in at -$449,748 in FY2024 and $1,006 in FY2023.
  • The Q2 2026 figure is the highest quarterly Change in Accrued Expenses in data going back to Q3 2024.
  • Per Business Quant, the preceding three quarters came in at -$12,988 (Q1 2026), -$8,772 (Q4 2025) and $8,163 (Q3 2025).
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 260,465.00
Mar 31, 2026 -12,988.00
Dec 31, 2025 -8,772.00
Sep 30, 2025 8,163.00
Jun 30, 2025 -62,557.00
Mar 31, 2025 92,174.00
Dec 31, 2024 -469,542.00
Sep 30, 2024 20,800.00
API Access

Translational Development Acquisition Change in Accrued Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-accured-expenses&ticker=TDACU&period=max&api_key=YOUR_API_KEY